← Open Payments lookup

REBECCA ABUOR: Open Payments

NPI 1356593974 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$426 in 15 payments from 6 companies in 2025. Trend: 2023 $300 · 2024 $199 · 2025 $426

Food & beverage: $426
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc6$192
Neuronetics, Inc.1$72
Otsuka America Pharmaceutical, Inc.3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Supernus Pharmaceuticals, Inc.2$40
Teva Pharmaceuticals USA, Inc.1$30

Products named: INVEGA SUSTENNA, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, Qelbree, UZEDY, SPRAVATO, ABILIFY MAINTENA, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.